Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News BioMark Diagnostics Inc C.BUX

Alternate Symbol(s):  BMKDF

Healthcare Diagnostics & Research
Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer, as well as glioblastoma (GBM), breast cancer, and head and neck cancer. It is also developing liquid biopsy tests for various cancer types, including glioblastoma... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:BUX)

BioMark Diagnostics Collaborative Lung Cancer Screening Project Honored by ADRIQ during the 35th Innovation Awards Gala

Newsfile 11 days ago

CSE Bulletin: MOC Eligibility Update

Newsfile November 27, 2025

BioMark Aligns with National Strategy to Slash Lung Cancer Mortality with Next-Gen Liquid Biopsy

Newsfile November 12, 2025

BioMark's Liquid Biopsy Platform Selected for Holistic German Lung Cancer Screening Trial

Newsfile October 7, 2025

BioMark Secures Key Patents in Asia's Largest Markets for Early Lung Cancer Liquid Biopsy

Newsfile September 29, 2025

BioMark Diagnostics Establishes African Market Presence Through Strategic Tunisia Healthcare Partnership

Newsfile August 12, 2025

BioMark Diagnostics Announces Expansion of Its Specialty Laboratory Services in Quebec to Accommodate Increased Demand from International Partnerships

Newsfile August 5, 2025

BioMark Diagnostics Highlights Fiscal Year 2025 Achievements and Sets Bold Strategic Milestones for 2025 - 2026

Newsfile July 30, 2025

BioMark Diagnostics Announces Breakthrough Publication Reinforcing Leadership in AI-Powered Metabolomics for Oncology

Newsfile May 20, 2025
View More News ››

Opinion & Analysis (CSE:BUX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:BUX)

New blood coming on board

could be something happening although it looks like Bux is moving around some shares, maybe moving out some. Check insiders banner. ...
geodcan - April 8, 2025

Finally, I let my bid expire

It was for 200k shares and steadily active for at least a year though Stockhouse never saw fit to post it. I did see it periodically on...
geodcan - January 15, 2025

Good til January

$5k bid been on this for a year or so above my initial purchase bid.  Still got Bux and Huang doing small insider buys to hold the...
geodcan - December 22, 2024

I just pre-refreshed my order

which for some reason just doesn't show as a viable buy, at least on SH. I see Bux and Huang are ponying up a little more, almost...
geodcan - July 15, 2024

RE:If the insiders quit manipulating the sp

Yes, 100% agree. At this stage, I peg the fair value at about .10 to .15 cents. So difficult to confirm with the share price management...
David8888 - July 12, 2024

If the insiders quit manipulating the sp

we would get a fairer asessment  of the real value of this company. Might motivate management to do something more businesslike to...
geodcan - July 11, 2024
View more Bullboard ››

Nuclear Vision Ltd.

Nuclear Vision Ltd.

Nuclear Vision Limited operates as a uranium exploration company. Its material property is the Regnault Project that consists ...
View More »